title: [Botulinum toxin and traumatic brain injury].
abstract: Botulinum toxin is a successful focal spasticity therapy. The aim of this article is to study the data of the literature concerning its utilisation in traumatic brain injured patients, whom motor and tonus disturbances are polymorphic, in their clinical presentation as well as in their evolution. Although there are few studies concerning its utilisation in such patients, none of them being controlled, its use seems interesting in focal spasticity treatment. It can contribute to improve functional abilities and comfort for these patients.
authors.affiliation: Clinique Napoléon, lac de Christus, 40990 Saint-Paul-Lès-Dax, France. duprey_emmanuelle_florence@yahoo.fr
authors.forename: E
authors.initials: E
authors.lastname: Duprey
authors.forename: P
authors.initials: P
authors.lastname: Dehail
authors.forename: E
authors.initials: E
authors.lastname: Cuny
authors.forename: P
authors.initials: P
authors.lastname: Arné
authors.forename: B
authors.initials: B
authors.lastname: Fernandez
authors.forename: P A
authors.initials: PA
authors.lastname: Joseph
authors.forename: J M
authors.initials: JM
authors.lastname: Mazaux
authors.forename: M
authors.initials: M
authors.lastname: Barat
mesh_terms: D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001905:Botulinum Toxins / Q000008:administration & dosage / Q000494:pharmacology*; D001930:Brain Injuries / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000209:etiology; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins